Matthew Handley and Ron Howrigon discuss the ongoing relevance of COVID, the cost of weight loss drugs in the US, and public opinion on prescription weight loss drugs. Key highlights

• COVID still matters, especially for those at risk

• The cost of weight loss drugs in the US compared to other countries

• The need for a free market economy in healthcare

• Public opinion on prescription weight loss drugs

• The potential impact of covering weight loss drugs under insurance

Resources mentioned

• Health System Tracker - How do prices of drugs for weight loss in the U.S. compare to peer nations’ prices?

• Kaiser Family Foundation - KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs

Facts

• COVID can still be severe for at-risk populations

• Vaccines can help prevent severe symptoms

• The US pays more for weight loss drugs compared to other countries

• The prevalence of obesity is high in the US

• The cost of covering weight loss drugs for all Americans would be significant

Action steps

• Stay informed about the ongoing impact of COVID

• Consider the cost of weight loss drugs and explore alternative options

• Share your opinion on prescription weight loss drugs

• Advocate for healthcare policies that promote a free market economy

  Listener challenge: Reflect on your own opinion about prescription weight loss drugs and consider the potential impact of covering them under insurance.  

• Matthew Handley on X

• Ron Howrigon on X

Subscribe to the Flatlining Podcast to never miss an episode and join the conversation about important healthcare topics.